Navigation Links
Marshall Edwards Announces $2 Million Private Placement
Date:9/28/2011

SAN DIEGO, Sept. 28, 2011 /PRNewswire/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today that it has entered into a definitive agreement with its majority shareholder, Novogen Limited, to sell common stock in a private placement for gross proceeds of $2 million, before deducting fees and expenses of the offering, through the sale of approximately 1.33 million shares of common stock. The offering is expected to close on September 30, 2011, subject to certain customary closing conditions.

"This transaction is another indication of Novogen's ongoing support of Marshall Edwards and our emerging oncology programs," said Daniel P. Gold, Ph.D., President and Chief Executive Officer of Marshall Edwards. "Net proceeds from this offering will be used to continue development of our two lead drug candidates, ME-143 and ME-344, and will enable us to advance these programs to meaningful clinical data points next year that we believe can create significant value for our shareholders."

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Marshall Edwards, Inc. nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Marshall Edwards

Marshall Edwards, Inc. (Nasdaq: MSHL) is a San Diego-based oncology company focused on the clinical development of novel anti-cancer therapeutics. The Company's lead programs focus on two families of small molecules that result in the inhibition of tumor cell metabolism. The first and most advanced is a
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
2. Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
3. Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
4. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
5. Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
6. Marshall Edwards Announces Closing of Asset Purchase Agreement With Novogen
7. Marshall Edwards Announces Private Placement
8. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
9. Marshall Edwards Receives Positive Response From NASDAQ
10. Marshall Edwards to Host Annual Meeting of Stockholders
11. Marshall Edwards Receives NASDAQ Notice Of Non-Compliance; Intends To Request Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Pharmaceutic Labs ... Facility" under section 503B of the FDA,s Drug ... title, the company is subject to Current Good ... bulk medications according to the highest standards of ... Part 211. To continuously comply with FDA regulations ...
(Date:5/28/2015)... 2015 The global departmental PACS market ... , Europe , Asia ... departmental PACS market is expected to reach $3,807.4 million by ... Browse through the TOC of global departmental PACS ... segments, with help of various tables and figures. ...
(Date:5/28/2015)... , May 28, 2015  Janssen Pharmaceuticals, Inc. (Janssen) ... initiation of CALLISTO, a new comprehensive clinical research program ... active cancer. The studies are evaluating the medicine for ... patients with a wide range of cancer types. ... venous thromboembolism (VTE), which is a blood clot in ...
Breaking Medicine Technology:Departmental PACS Market is Expected to Reach $3,807.4 Billion by 2019, at a CAGR of 10.0% From 2014 to 2019 2Departmental PACS Market is Expected to Reach $3,807.4 Billion by 2019, at a CAGR of 10.0% From 2014 to 2019 3New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 2New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 3New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 4New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 5New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 6New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 7New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 8New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 9New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 10New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 11New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients with Cancer 12
(Date:5/28/2015)... May 28, 2015 Medelis, Inc., a ... joined the company in the role of president. , “ ... in the CRO industry,” said Larry Flanagan, Medelis’ CEO and ... company through our next phase of growth.” , Taaffe ... growth from nine employees to over 4,500 employees, achieving 12 ...
(Date:5/28/2015)... May 28, 2015 Altima Technologies, ... Device Library for documenting and diagramming data center ... for the following product lines: , Manufacturer ... 5500, Chatsworth Products N-Series TeraFrame Cabinet, Middle Atlantic ... Eclipse, Fore Systems ForeRunner, Marantz America MM Series, ...
(Date:5/28/2015)... 2015 Nidra Herbal Sleep Supplement features a ... body. A non-addictive supplement, Nidra Herbal Sleep Supplement is more ... will leave users with a real sense of wellbeing the ... Ayurveda, which translates as the “Science or Knowledge of Life”, ... and is a holistic system of knowledge which combines contemplation, ...
(Date:5/28/2015)... ZH Healthcare (ZH), a leading provider of Health ... the Electronic Health Solution, on the Amazon AWS platform ... all AWS users worldwide. , ZH Healthcare is ... Freemium, SaaS, Electronic Health Solution (EHS). BlueEHS offers ... practice management system (PMS), e-Rx, lab interfaces, a telemedicine-enabled ...
(Date:5/28/2015)... The connected car is gaining more ... new vehicles have some iteration of a connected offering ... motor insurance companies as the data collected can be ... usage-based insurance (UBI). This is the primary reason that ... Europe 2015 Conference & Exhibition. , Andrew Pym, ...
Breaking Medicine News(10 mins):Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2Health News:Ayurveda Herba Corp’s Revolutionary Herbal Sleep Supplement is Now Available from Amazon.com 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 3Health News:TU-Automotive: North America’s Leading Insurers Head to Chicago as Connected Car Motor Insurance Shifts up a Gear 2Health News:TU-Automotive: North America’s Leading Insurers Head to Chicago as Connected Car Motor Insurance Shifts up a Gear 3
... soon become part of the Indian government's efforts to reach ... HIV/AIDS and promote the use of condoms.// ,Where ... the idea is to reach out through the soft drinks ... estimated at over one million outlets across the country. ...
... form of cancer and nearly one out of every three cancers ... the more alarming is that 73% of people with fair skin ... they still get sunburnt despite almost two thirds worrying it could ... is the cause of nearly all types of skin cancer occurring ...
... interest in eating during old age is the thing of ... which will help older people eat nutritious food and take ... at the institute advise that High fibre in the form ... fight diabetes, heart disease and diverticulosis. Folic acid (400 micrograms ...
... a dietary supplement used in treating obesity and people ... weight loss. The researcher that had systematically reviewed the ... in the latest issue of The Cochrane Library.// ... controlled trials that included 1,131 overweight or obese adults. ...
... can mean much athletic activity that is bad for ... quite a common cause of hospitalization for young adults.// ... Sports Medicine for Coaches Fall Sports Safety Seminar, researchers ... York City’s Hospital for Special Surgery, had said it ...
... South India wake up to the lovely smell of homemade ... coffee lovers now, with firm evidence from recent research. // ... and has been found to contain substances called as anti-oxidants, ... have been linked to a number of potential health benefits, ...
Cached Medicine News:Health News:All Play Is No Good For Health 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: